Result of AGM
Updated : 13:24
Feedback plc
Result of Annual General Meeting
London, UK, 5 November 2020: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces that at its annual general meeting held earlier today, all resolutions were duly passed on a poll. The proxy voting results of the resolutions are included below.
Resolutions | Votes For* | % of votes cast** | Votes Against | % of votes cast** | Votes Withheld** | Total votes cast** |
| ||||||
1. To receive and adopt the annual report and accounts for the year ended 31 May 2020 | 504,134,927 | 100.00% | - | 0.00% | 22,000 | 503,044,792 |
| ||||||
2. To elect Adam Denning as a director | 504,152,622 | 100.00% | 3,305 | 0.00% | 1,000 | 503,065,534 |
| ||||||
3. To elect Philipp Prince as a director | 479,902,622 | 95.19% | 24,253,305 | 4.81% | 1,000 | 503,065,534 |
| ||||||
4. To re-elect Simon Sturge as a director | 504,152,486 | 100.00% | 3,441 | 0.00% | 1,000 | 503,065,670 |
| ||||||
5. To appoint Price Bailey LLP as auditors of the Company | 504,118,963 | 99.99% | 36,964 | 0.01% | 1,000 | 503,099,193 |
| ||||||
6. To authorise the directors to allot relevant securities equivalent to up to two thirds of the Company's issued share capital, subject to certain conditions | 504,027,372 | 100.00% | 3,305 | 0.00% | 126,250 | 502,940,284 |
| ||||||
7. To authorise the directors to allot relevant securities equivalent to up to 10 per cent. of the Company's issued share capital on a non-pre-emptive basis subject to certain conditions | 478,945,731 | 95.01% | 25,135,091 | 4.99% | 76,205 | 502,990,429 |
Notes:
* "Votes For" include votes giving the Chairman discretion.
** "Votes Withheld" are not votes in law and do not count in the number of votes counted for or against a resolution, or towards the total votes cast.
-Ends-
Enquiries:
Feedback plc Tom Oakley, CEO Lindsay Melvin, CFO | +44 (0)1954 718072 |
|
|
Allenby Capital Limited (Nominated Adviser) David Worlidge / Asha Chotai | +44 (0)20 3328 5656 |
|
|
Peterhouse Capital Limited (Joint Broker) Lucy Williams / Duncan Vasey | +44 (0)20 7469 0936 |
|
|
Stanford Capital Partners Limited (Joint Broker) Patrick Claridge / John Howes | +44 20 3815 8880 |
|
|
Walbrook PR Ltd | Tel: 020 7933 8780 or feedbackplc@walbrookpr.com |
Paul McManus/Nick Rome/Nicholas Johnson | 07980 541 893 or 07748 325 236 or 07884 664 686 |
Notes to Editors
Feedback plc (AIM: FDBK) is a medical imaging technology business. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS")-based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care facilitators. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of diagnosis.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.